Literature DB >> 10216283

Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.

S W Sakr1, D L Williams, G W Stoudt, M C Phillips, G H Rothblat.   

Abstract

In the present study apolipoprotein-mediated free cholesterol (FC) efflux was studied in J774 macrophages having normal cholesterol levels using an experimental design in which efflux occurs in the absence of contributions from cholesteryl ester hydrolysis. The results show that cAMP induces both saturable apolipoprotein (apo) A-I-mediated FC efflux and saturable apo A-I cell-surface binding, suggesting a link between these processes. However, the EC50 for efflux was 5-7-fold lower than the Kd for binding in both control and cAMP-stimulated cells. This dissociation between apo A-I binding and FC efflux was also seen in cells treated for 1 h with probucol which completely blocked FC efflux without affecting apo A-I specific binding. Thus, cAMP-stimulated FC efflux involves probucol-sensitive processes distinct from apo A-I binding to its putative cell surface receptor. FC efflux was also dramatically stimulated in elicited mouse peritoneal macrophages, suggesting that cAMP-regulated apolipoprotein-mediated FC efflux may be important in cholesterol homeostasis in normal macrophages. The presence of a cAMP-inducible cell protein that interacts with lipid-free apo A-I was investigated by chemical cross-linking of 125I-apo A-I with J774 cell surface proteins which revealed a Mr 200 kDa component when the cells were treated with cAMP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216283     DOI: 10.1016/s1388-1981(99)00041-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1.

Authors:  Alisha D Howard; Philip B Verghese; Estela L Arrese; Jose L Soulages
Journal:  Mol Cell Biochem       Date:  2010-06-10       Impact factor: 3.396

2.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

3.  Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol.

Authors:  Jun Zhang; Sutang Cai; Blake R Peterson; Penny M Kris-Etherton; John P Vanden Heuvel
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

Review 4.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

5.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.

Authors:  A T Remaley; S Rust; M Rosier; C Knapper; L Naudin; C Broccardo; K M Peterson; C Koch; I Arnould; C Prades; N Duverger; H Funke; G Assman; M Dinger; M Dean; G Chimini; S Santamarina-Fojo; D S Fredrickson; P Denefle; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.

Authors:  B L Vaisman; G Lambert; M Amar; C Joyce; T Ito; R D Shamburek; W J Cain; J Fruchart-Najib; E D Neufeld; A T Remaley; H B Brewer; S Santamarina-Fojo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 7.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

9.  Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.

Authors:  Bronwyn E Brown; Estelle Nobecourt; Jingmin Zeng; Alicia J Jenkins; Kerry-Anne Rye; Michael J Davies
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.

Authors:  Claudine Tardy; Marine Goffinet; Nadia Boubekeur; Guy Cholez; Rose Ackermann; Gavin Sy; Constance Keyserling; Narendra Lalwani; John F Paolini; Jean-Louis Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.